← Eichor
Condition: Hiv 1 Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hiv 1

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Antiretrovirals Combined With Antibodies for HIV-1 Cure In Africa
Phase 2 · 4 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT06205602A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and W
Phase 1 · 3 location(s) · International AIDS Vaccine Initiative · NCT06617091Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therap
Phase N/A · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT04160455A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
Phase 1 · 11 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07390955A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Phase 2 · 123 location(s) · ViiV Healthcare · NCT07202546Cannabis Use, Cognition, and the Endocannabinoid System in HIV
EARLY_Phase 1 · 1 location(s) · University of California, San Diego · NCT04883255Viral Infection of HSPC Impacts Hematopoiesis
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06458504Caspofungin for Pneumocystis Pneumonia in PLWHIV.
Phase N/A · 1 location(s) · Instituto Nacional de Enfermedades Respiratorias · NCT06691321A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.C
Phase 1 · 6 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06796686A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test
NA · 3 location(s) · bioLytical Laboratories · NCT07563309Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
Phase 1 · 1 location(s) · ViiV Healthcare · NCT07636928Triage Survey for Infectious Disease Eligibility
Phase N/A · 1 location(s) · Brooklyn Clinical Research · NCT06492187Switch to Dolutegravir Plus Lamivudine Dual-Therapy in Transgender Women Living With HIV on Virologically Suppressive An
Phase 4 · 1 location(s) · UBATEC · NCT06967753A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1
Phase 1/Phase 2 · 1 location(s) · ViiV Healthcare · NCT07275606Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
Phase 1/Phase 2 · 2 location(s) · University of Melbourne · NCT05187429#AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-i
NA · 28 location(s) · Casper Rokx · NCT06900829HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Phase 2 · 1 location(s) · Centre de Recherches et d'Etude sur la Pathologie Tropicale · NCT04513626Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Phase 1/Phase 2 · 8 location(s) · ViiV Healthcare · NCT05674656Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
NA · 1 location(s) · Syracuse University · NCT06648629Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adult
Phase 3 · 3 location(s) · Gilead Sciences · NCT07682961Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
Phase 2 · 2 location(s) · Massachusetts General Hospital · NCT06554717Impacts of HIV Treatment Regimens on Archived Drug Resistance
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT07643948Observational PIC Destination Cohort
Phase N/A · 4 location(s) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Ot · NCT05985642Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05419024Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control
Phase 2 · 17 location(s) · ANRS, Emerging Infectious Diseases · NCT05300035A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and Wi
Phase 1 · 6 location(s) · BioNTech SE · NCT07392372HIV Resistance, Molecular Epidemiology and New Treatment Strategies in the Eastern European Region and in Russia
Phase N/A · 4 location(s) · Euresist Network GEIE · NCT06127290
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.